Insights on Dissemination of Lung Cancer

Recruiting now

Conditions studied: Oncology & Epidemiology & Lung Cancer

In brief

In patients with resectable NSCLC treated with surgery alone or with surgery as part of a multimodal treatment; CTC, ctDNA, STAS, and lymph node micrometastasis levels will be evaluated to see if they are associated with recurrence patterns and long-term outcomes.

Key facts

Study ID

NCT07476495

Run by

IRCCS Azienda Ospedaliero-Universitaria di Bologna

People needed

100

Starts

2026-02-01

Expected to finish

2029-02-01

Last updated by the study team

2026-03-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years;
• Preoperative diagnosis of resectable stage cIA-cIIIA NSCLC (adenocarcinoma or squamous cell carcinoma);
• Patients deemed fit for surgical or multimodal treatment;
• Informed consent obtained;
• Treatment, including multimodal treatment, involving surgery.

You may not qualify if…

• Histology other than adenocarcinoma or squamous cell carcinoma;
• Other neoplastic diseases concurrent with or undergoing treatment or treated with systemic therapies in the previous three years;
• Age <18 years;
• No need for surgery.

Where it is running

• IRCCS Azienda Ospedaliero-Università di Bologna — Bologna, Bologna, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.